| AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis Molecular Cancer Research 17 (9), 1787-1800, 2019 | 55 | 2019 |
| Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis A Vaishnavi, J Juan, M Jacob, C Stehn, EE Gardner, MT Scherzer, ... Cancer research 82 (22), 4261-4273, 2022 | 8 | 2022 |
| Genetic silencing of AKT induces melanoma cell death via mTOR suppression GL Parkman, T Turapov, DA Kircher, WJ Burnett, CM Stehn, K O'Toole, ... Molecular Cancer Therapeutics 23 (3), 301-315, 2024 | 1 | 2024 |
| Genetic silencing of AKT induces melanoma cell death GL Parkman, T Turapov, DA Kircher, WJ Burnett, CM Stehn, K O’Toole, ... bioRxiv, 2022.08. 15.504039, 2022 | 1 | 2022 |
| Combined inhibition of RAF, MEK, and FAK attenuates melanoma brain metastases and prolongs survival in preclinical models KA Stanley, JD Almazan, T Turapov, DA Kircher, GL Parkman, MKN Field, ... Cancer Research 84 (6_Supplement), 4127-4127, 2024 | | 2024 |
| Abstract B009: Characterizing the super enhancer landscape of H3K27me3 loss in MPNST and DIPG CM Stehn, M Bhunia, K Williams, AT Larsson, A Caride, JH Lee, T Ordog, ... Cancer Research 84 (5_Supplement_1), B009-B009, 2024 | | 2024 |
| Newer generation mTOR inhibition represents effective therapeutic strategy for BRAF-mutant melanoma GL Parkman, T Turapov, D Kircher, W Burnett, C Stehn, K O'Toole, ... Cancer Research 83 (7_Supplement), 427-427, 2023 | | 2023 |
| Methylation profiling reveals the role of PRC2 in regulating DNA methylome changes in malignant peripheral nerve sheath tumors CM Stehn, M Bhunia, KB Williams, AT Larsson, DA Largaespada Cancer Research 83 (7_Supplement), 6011-6011, 2023 | | 2023 |
| Integrative multiomic analysis reveals NOTCH signaling is derepressed by loss of PRC2 in malignant peripheral nerve sheath tumors. M Bhunia, CM Stehn, M Madala, K Williams, A Larsson, T Jubenville, ... CANCER RESEARCH 82 (23), 2022 | | 2022 |
| Methylation profiling reveals the role of PRC2 in regulating DNA methylome stochasticity in malignant peripheral nerve sheath tumors. CM Stehn, M Bhunia, S Suppiah, A Herman, G Zadeh, D Largaespada CANCER RESEARCH 82 (23), 2022 | | 2022 |
| Abstract A007: Integrative multiomic analysis reveals NOTCH signaling is derepressed by loss of PRC2 in malignant peripheral nerve sheath tumors M Bhunia, CM Stehn, M Madala, K Williams, A Larsson, T Jubenville, ... Cancer Research 82 (23_Supplement_2), A007-A007, 2022 | | 2022 |
| Abstract A010: Methylation profiling reveals the role of PRC2 in regulating DNA methylome stochasticity in malignant peripheral nerve sheath tumors CM Stehn, M Bhunia, S Suppiah, A Herman, G Zadeh, D Largaespada Cancer Research 82 (23_Supplement_2), A010-A010, 2022 | | 2022 |
| Transposon Mutagenesis Reveals RBMS3 as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis A Vaishnavi, J Juan, MT Scherzer, JE VanVeen, C Stehn, CS Hackett, ... bioRxiv, 2022.02. 28.482366, 2022 | | 2022 |
| Model-dependent outcomes: Sex as a biological variable in preclinical mouse models of melanoma GL Parkman, DA Kircher, CM Stehn, M McMahon, SL Holmen Pigment cell & melanoma research, 2021 | | 2021 |
| THER-07. DEVELOPMENT OF A NEW MOLECULAR PREDICTOR FOR RISK OF BRAIN METASTASES AND EFFICACY OF TARGETED THERAPY IN MELANOMA H Colman, K Boucher, C Stehn, D Kircher, S Holmen Neuro-oncology Advances 1 (Suppl 1), i12, 2019 | | 2019 |
Gennie Parkman, PhD, MSCIPostdoctoral Research Fellow, Huntsman Cancer InstituteVerified email at hci.utah.edu
